Follow
David Morton
David Morton
Verified email at deakin.edu.au
Title
Cited by
Cited by
Year
The cohesive-adhesive balances in dry powder inhaler formulations I: direct quantification by atomic force microscopy
P Begat, DAV Morton, JN Staniforth, R Price
Pharmaceutical research 21, 1591-1597, 2004
2802004
Miniature inhalation therapy platform using surface acoustic wave microfluidic atomization
A Qi, JR Friend, LY Yeo, DAV Morton, MP McIntosh, L Spiccia
Lab on a Chip 9 (15), 2184-2193, 2009
2012009
To protect and to preserve: novel preservation strategies for extracellular vesicles
GD Kusuma, M Barabadi, JL Tan, DAV Morton, JE Frith, R Lim
Frontiers in Pharmacology 9, 417722, 2018
1722018
The cohesive-adhesive balances in dry powder inhaler formulations II: influence on fine particle delivery characteristics
P Begat, DAV Morton, JN Staniforth, R Price
Pharmaceutical research 21, 1826-1833, 2004
1692004
New developments in dry powder pulmonary vaccine delivery
T Sou, EN Meeusen, M de Veer, DAV Morton, LM Kaminskas, ...
Trends in biotechnology 29 (4), 191-198, 2011
1652011
Ultrasonic nebulization platforms for pulmonary drug delivery
LY Yeo, JR Friend, MP McIntosh, ENT Meeusen, DAV Morton
Expert opinion on drug delivery 7 (6), 663-679, 2010
1582010
The effect of amino acid excipients on morphology and solid-state properties of multi-component spray-dried formulations for pulmonary delivery of biomacromolecules
T Sou, LM Kaminskas, TH Nguyen, R Carlberg, MP McIntosh, DAV Morton
European Journal of Pharmaceutics and Biopharmaceutics 83 (2), 234-243, 2013
1552013
Drug–lactose binding aspects in adhesive mixtures: controlling performance in dry powder inhaler formulations by altering lactose carrier surfaces
QT Zhou, DAV Morton
Advanced drug delivery reviews 64 (3), 275-284, 2012
1412012
The influence of force control agents on the cohesive-adhesive balance in dry powder inhaler formulations
P Begat, R Price, H Harris, DAV Morton, JN Staniforth
KONA Powder and Particle Journal 23, 109-121, 2005
1382005
Improving powder flow properties of a cohesive lactose monohydrate powder by intensive mechanical dry coating
Q Zhou, B Armstrong, I Larson, PJ Stewart, DAV Morton
Journal of pharmaceutical sciences 99 (2), 969-981, 2010
1362010
Improving aerosolization of drug powders by reducing powder intrinsic cohesion via a mechanical dry coating approach
QT Zhou, L Qu, I Larson, PJ Stewart, DAV Morton
International journal of pharmaceutics 394 (1-2), 50-59, 2010
1312010
Understanding the influence of powder flowability, fluidization and de-agglomeration characteristics on the aerosolization of pharmaceutical model powders
QT Zhou, B Armstrong, I Larson, PJ Stewart, DAV Morton
European Journal of Pharmaceutical Sciences 40 (5), 412-421, 2010
1212010
The role of force control agents in high‐dose dry powder inhaler formulations
P Begat, DAV Morton, J Shur, P Kippax, JN Staniforth, R Price
Journal of Pharmaceutical Sciences 98 (8), 2770-2783, 2009
1132009
Characterization of the surface properties of a model pharmaceutical fine powder modified with a pharmaceutical lubricant to improve flow via a mechanical dry coating approach
QT Zhou, JA Denman, T Gengenbach, S Das, L Qu, H Zhang, I Larson, ...
Journal of pharmaceutical sciences 100 (8), 3421-3430, 2011
972011
Determination of the polar and total surface energy distributions of particulates by inverse gas chromatography
SC Das, I Larson, DAV Morton, PJ Stewart
Langmuir 27 (2), 521-523, 2011
972011
Relationship between surface concentration of L-leucine and bulk powder properties in spray dried formulations
S Mangal, F Meiser, G Tan, T Gengenbach, J Denman, MR Rowles, ...
European Journal of Pharmaceutics and Biopharmaceutics 94, 160-169, 2015
922015
Effect of Surface Coating with Magnesium Stearate via Mechanical Dry Powder Coating Approach on the Aerosol Performance of Micronized Drug Powders from …
Q Zhou, L Qu, T Gengenbach, I Larson, PJ Stewart, DAV Morton
Aaps Pharmscitech 14, 38-44, 2013
882013
Investigation of the extent of surface coating via mechanofusion with varying additive levels and the influences on bulk powder flow properties
QT Zhou, L Qu, T Gengenbach, JA Denman, I Larson, PJ Stewart, ...
International journal of pharmaceutics 413 (1-2), 36-43, 2011
852011
Composition, device, and method for treating sexual dysfunction via inhalation
J Staniforth, D Morton, M Tobyn, S Eason, Q Harmer, D Ganderton
US Patent App. 10/621,964, 2004
782004
Formulations for use in inhaler devices
JN Staniforth, DAV Morton, R Gill, G Brambilla, R Musa, L Ferrarini
US Patent 8,182,791, 2012
772012
The system can't perform the operation now. Try again later.
Articles 1–20